All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2004-001991-37 | A pilot study investigating the effects of a combination of local and systemic anti-inflammatory adjuncts in patients undergoing vitrectomy and silicone oil for established Proliferative Vitreoretinop... | 2007-11-01 | due-trials |
Not reported | 2005-002389-13 | Endothelial Lamellar Keratoplasty (ELK) with Tisseel adhesive. | 2007-02-09 | due-trials |
Completed, but no date, and reported results | 2005-002391-14 | Pulsed Intravenous Methylprednisolone for Ocular Pemphigoid- A Pilot Study | bad-data | |
Reported results | 2006-000653-22 | The UK Glaucoma Treatment Study | 2011-07-19 | due-trials |
Reported results | 2006-001544-31 | A randomised, double-masked, phase 3 study of the efficacy and safety of Avastin® (bevacizumab) intravitreal injections compared to best available therapy in subjects with choroidal neovascularizatio... | 2008-12-02 | due-trials |
Reported results | 2006-004826-10 | An observational case series to assess the effects of intravitreal Bevacizumab on eyes with neovascular glaucoma | 2009-04-15 | due-trials |
Reported results Terminated | 2006-005008-15 | Exploratory study of intravitreal clindamycin and dexamethasone in the treatment of acute toxoplasma chorioretinitis associated vitritis | 2009-12-09 | due-trials |
Reported results Terminated | 2006-005400-14 | PERIOPERATIVE INTRAVITREAL TRIAMCINOLONE IN PHAKOEMULSIFICATION FOR CONCURRENT CLINICALLY SIGNIFICANT DIABETIC MACULAR OEDEMA | 2009-07-21 | due-trials |
Reported results Terminated | 2006-006728-20 | The use of intraocular methotrexate to treat uveitis: a safety and efficacy study | 2009-09-16 | due-trials |
Reported results | 2007-000705-30 | efficacy of pegaptanib sodium (macugen) on uveitic cystoid macular oedema: an exploratory study | 2010-06-28 | due-trials |
Reported results Terminated | 2007-000780-21 | A randomised, single-masked, Phase IV pilot study of the efficacy and safety of adjunctive intravitreal Avastin® (bevacizumab) in the prevention of early postoperative vitreous haemorrhage following d... | 2008-08-22 | due-trials |
Reported results | 2007-000847-89 | Full Title of Study: Diabetic macular oedema: a prospective randomised trial of management with intravitreal bevacizumab (Avastin) versus conventional laser therapy | 2010-07-26 | due-trials |
Reported results | 2007-005138-35 | Triamcinolone acetonide to prevent PVR in eyes undergoing vitreoretinal surgery for open globe trauma | 2013-12-02 | due-trials |
Reported results | 2008-003689-24 | Lotemax in the treatment of chronic anterior uveitis: a pilot study | 2010-06-28 | due-trials |
Reported results | 2008-007984-17 | Pilot randomised placebo-controlled double-masked clinical trial of subconjunctival Bevacizumab on eyes with recent onset of corneal neovascularisation | 2014-01-20 | due-trials |
Reported results | 2010-021722-35 | Diabetic macula oedema: A prospective randomised study comparing the detailed functional and anatomical changes of repeated pan anti-VEGF therapy with ranibizumab versus conventional macular laser the... | 2012-07-16 | due-trials |
Reported results | 2010-024062-22 | A prospective, randomised controlled trial of Ranibizumab pre-treatment in Diabetic Vitrectomy – a pilot study. | 2013-11-01 | due-trials |
Reported results | 2011-001869-41 | An exploratory study of ranibizumab (Lucentis) for treatment of uveitic patients with refractory cystoid macular oedema. 'The LIMO study' | 2014-06-18 | due-trials |
Reported results Terminated | 2011-003304-20 | Randomised Controlled Trial of Intravitreal therapy with Avastin compared to Observation in Patients with Diabetic Ischaemic Macular Oedema ‘The DIME study’ | 2012-10-15 | due-trials |
Reported results | 2011-003339-74 | A Prospective Randomised Controlled Trial of Intravitreal Ozurdex and Macular Laser Therapy versus Macular Laser Therapy only in Diabetic Macular Oedema (OZLASE study) | 2013-10-22 | due-trials |
Reported results | 2011-004498-96 | Ozurdex in proliferative vitreoretinopathy; a randomised control trial | 2015-02-17 | due-trials |
Reported results | 2012-003661-17 | A Multicentre Prospective Open-label Randomised Clinical Trial Comparing the Efficacy of Fixed versus PRN dosing of 700 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in patients... | 2014-11-10 | due-trials |
Reported results Terminated | 2013-000031-27 | Intravitreal Ranibizumab (Lucentis) Therapy in Patients with Diabetic Ischaemic Macular Oedema (DIME) | 2014-02-04 | due-trials |
Reported results Terminated | 2013-000395-15 | The use of bevacizumab as a modulator of wound healing following trabeculectomy surgery: A Single Centre Randomised Controlled Phase III Pilot Study. | 2019-09-05 | due-trials |
Reported results | 2013-003272-12 | Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy | 2016-12-21 | due-trials |
Reported results | 2014-000272-26 | A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eyle... | 2018-11-21 | due-trials |
Other | 2014-002193-37 | A phase 3 multi-centre double-masked randomised controlled trial of adjunctive intraocular and periocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal s... | not-yet-due | |
Reported results | 2014-002381-73 | Individualizing therapy for neovascular age-related macular degeneration with aflibercept | 2018-01-26 | due-trials |
Reported results | 2015-003723-65 | Aflibercept (Eylea®) for macular oedema associated with underlying Retinitis Pigmentosa (AMOUR) | 2017-07-31 | due-trials |
Reported results | 2016-002523-28 | A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa | 2016-10-20 | due-trials |